Since the beginning of 2021., the organisational and strategy move was made in favour of stronger focus and company investment into internal R&D projects and own intellectual property. In line with that, Scientific Operations are organised within 3 important pillars: Research & development, Process development and Global regulatory affairs.
We believe in going beyond the products and technologies that we already acquired. Our new targets are innovative projects (both medical devices and pharmaceutical drugs) and complex technologies (e.g. nano – emulsions, suspensions) with continued focus on offering solutions for eye, nose and skin therapy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.